• 제목/요약/키워드: Ricin Vaccine

검색결과 1건 처리시간 0.013초

독성을 제거한 재조합 리신 백신 개발 및 효능평가 (Development of Non-toxic Recombinant Ricin Vaccine and Evaluation of Vaccine Efficacy)

  • 윤형석;조혜은;송동현;유치호;송영조;허경행
    • 한국군사과학기술학회지
    • /
    • 제27권2호
    • /
    • pp.304-310
    • /
    • 2024
  • Ricin is a highly toxic protein which is produced in the seeds of the castor oil plant. Ricin toxin A chain has ribosomal RNA N-glycosylase activity that irreversibly hydrolyses the N-glycosidic bond of the adenine residue at position 4324 within the 28S rRNA. In this study, we developed non-toxic recombinant ricin vaccine(R51) in E. coli expression system, and evaluated efficacy of the R51 according to adjuvants. When the R51 was administered using aluminum hydroxide as an adjuvant, the vaccine efficacy was higher than that of TLR agonists or aluminum phosphate. Because it is time-consuming to administer the vaccine three times at three-week intervals, we investigated the survival rate and antibody titer of mice according to the change of time interval of vaccination. Interestingly, there was no difference in survival rate and antibody titer when R51 was administered at 0, 1, and 3 weeks or 0, 2, and 4 weeks compared to when administered at 0, 3, and 6 weeks. Therefore, the developed R51 vaccine is promising to protect soldiers from Ricin attack.